172 related articles for article (PubMed ID: 36840969)
1. The Oral Bioavailability and Effect of Various Gastric Conditions on the Pharmacokinetics of Dersimelagon in Healthy Adult Volunteers.
Ogawa K; Ide R; Belongie K; Tsuda M; Kawanishi H; Teng R; Ogasawara A
Clin Pharmacol Drug Dev; 2023 May; 12(5):493-501. PubMed ID: 36840969
[TBL] [Abstract][Full Text] [Related]
2. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
Bramer SL; Forbes WP
Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883
[TBL] [Abstract][Full Text] [Related]
3. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
4. Absorption, metabolism, and excretion of [
Tsuda M; Ogawa K; Endou T; Goto T; Ogasawara Y; Ogasawara A
Pharmacol Res Perspect; 2023 Jun; 11(3):e01084. PubMed ID: 37078227
[TBL] [Abstract][Full Text] [Related]
5. Results from a first-in-human study of dersimelagon, an investigational oral selective MC1R agonist.
Ogasawara A; Ogawa K; Ide R; Ikenaga Y; Fukunaga C; Nakayama S; Tsuda M
Eur J Clin Pharmacol; 2023 Jun; 79(6):801-813. PubMed ID: 37060458
[TBL] [Abstract][Full Text] [Related]
6. Effect of Hepatic and Renal Impairment on the Pharmacokinetics of Dersimelagon (MT-7117), an Oral Melanocortin-1 Receptor Agonist.
Ogasawara A; Ide R; Inoue S; Teng R; Kawaguchi A
Clin Pharmacol Drug Dev; 2024 May; ():. PubMed ID: 38746989
[TBL] [Abstract][Full Text] [Related]
7. When Bioequivalence in Healthy Volunteers May not Translate to Bioequivalence in Patients: Differential Effects of Increased Gastric pH on the Pharmacokinetics of Levothyroxine Capsules and Tablets.
Seng Yue C; Benvenga S; Scarsi C; Loprete L; Ducharme MP
J Pharm Pharm Sci; 2015; 18(5):844-55. PubMed ID: 26670370
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability and Pharmacokinetics of TRPV1 Antagonist Mavatrep (JNJ-39439335) Tablet and Capsule Formulations in Healthy Men: Two Open-Label, Crossover, Single-Dose Phase 1 Studies.
Manitpisitkul P; Shalayda K; Russell L; Sanga P; Williams Y; Solanki B; Caruso J; Moyer JA
Clin Pharmacol Drug Dev; 2018 Sep; 7(7):699-711. PubMed ID: 29125700
[TBL] [Abstract][Full Text] [Related]
9. Dose proportionality and the effects of food on bioavailability of an immediate-release oxycodone hydrochloride tablet designed to discourage tampering and its relative bioavailability compared with a marketed oxycodone tablet under fed conditions: a single-dose, randomized, open-label, 5-way crossover study in healthy volunteers.
Bass A; Stark JG; Pixton GC; Sommerville KW; Zamora CA; Leibowitz M; Rolleri R
Clin Ther; 2012 Jul; 34(7):1601-12. PubMed ID: 22717418
[TBL] [Abstract][Full Text] [Related]
10. Preclinical and Clinical Pharmacokinetics and Bioavailability in Healthy Volunteers of a Novel Formulation of the Selective P2X3 Receptor Antagonist Eliapixant.
Francke K; Chattopadhyay N; Klein S; Rottmann A; Krickau D; van de Wetering J; Friedrich C
Eur J Drug Metab Pharmacokinet; 2023 Jan; 48(1):75-87. PubMed ID: 36469250
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and Safety of Posaconazole Administered by Intravenous Solution and Oral Tablet in Healthy Chinese Subjects and Effect of Food on Tablet Bioavailability.
Li H; Wei Y; Zhang S; Xu L; Jiang J; Qiu Y; Mangin E; Zhao XM; Xie S
Clin Drug Investig; 2019 Nov; 39(11):1109-1116. PubMed ID: 31432392
[TBL] [Abstract][Full Text] [Related]
12. Single-dose pharmacokinetics of 2 or 3 tablets of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) under fed and fasted conditions: two randomized open-label trials.
Devarakonda K; Kostenbader K; Giuliani MJ; Young JL
BMC Pharmacol Toxicol; 2015 Nov; 16():31. PubMed ID: 26614499
[TBL] [Abstract][Full Text] [Related]
13. Effect of Food and Esomeprazole on the Pharmacokinetics of Alectinib, a Highly Selective ALK Inhibitor, in Healthy Subjects.
Morcos PN; Guerini E; Parrott N; Dall G; Blotner S; Bogman K; Sturm C; Balas B; Martin-Facklam M; Phipps A
Clin Pharmacol Drug Dev; 2017 Jul; 6(4):388-397. PubMed ID: 27545320
[TBL] [Abstract][Full Text] [Related]
14. An Integrated Population Pharmacokinetic Analysis for Posaconazole Oral Suspension, Delayed-Release Tablet, and Intravenous Infusion in Healthy Volunteers.
Chen L; Krekels EHJ; Heijnen AR; Knibbe CAJ; Brüggemann RJ
Drugs; 2023 Jan; 83(1):75-86. PubMed ID: 36607589
[TBL] [Abstract][Full Text] [Related]
15. Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults.
Courtney R; Wexler D; Radwanski E; Lim J; Laughlin M
Br J Clin Pharmacol; 2004 Feb; 57(2):218-22. PubMed ID: 14748822
[TBL] [Abstract][Full Text] [Related]
16. Dersimelagon in Erythropoietic Protoporphyrias.
Balwani M; Bonkovsky HL; Levy C; Anderson KE; Bissell DM; Parker C; Takahashi F; Desnick RJ; Belongie K;
N Engl J Med; 2023 Apr; 388(15):1376-1385. PubMed ID: 37043653
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and Safety of Levetiracetam Extended-Release Tablets and Relative Bioavailability Compared with Immediate-Release Tablets in Healthy Chinese Subjects.
Wang M; Wang M; Zhang Q; Zong S; Lv C
Eur J Drug Metab Pharmacokinet; 2018 Aug; 43(4):405-413. PubMed ID: 29383569
[TBL] [Abstract][Full Text] [Related]
18. Comparative Pharmacokinetics of a Controlled-release Pregabalin Tablet (GLA5PR GLARS-NF1) and an Immediate-release Pregabalin Capsule in Healthy Male Volunteers.
Kim TE; Jeon JY; Gu N; Chang Kwon M; Kim MG
Clin Ther; 2018 Dec; 40(12):2112-2124. PubMed ID: 30497798
[TBL] [Abstract][Full Text] [Related]
19. Relative Bioavailability and Food Effect Evaluation for 2 Tablet Formulations of Asciminib in a 2-Arm, Crossover, Randomized, Open-Label Study in Healthy Volunteers.
Menssen HD; Quinlan M; Kemp C; Tian X
Clin Pharmacol Drug Dev; 2019 Apr; 8(3):385-394. PubMed ID: 30059193
[TBL] [Abstract][Full Text] [Related]
20. Effect of pH and comedication on gastrointestinal absorption of posaconazole: monitoring of intraluminal and plasma drug concentrations.
Walravens J; Brouwers J; Spriet I; Tack J; Annaert P; Augustijns P
Clin Pharmacokinet; 2011 Nov; 50(11):725-34. PubMed ID: 21973269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
